| Not Yet Recruiting | SCALp Cooling for pReventing aLopecia With nEw anTibody-drug Conjugates NCT07474558 | Jules Bordet Institute | Phase 2 |
| Recruiting | Evaluation of Scalp Cooling During Chemotherapy on Quality of Life and the Potential Role of Single Nucleotide NCT07422376 | Charles Mays | N/A |
| Enrolling By Invitation | Study to Evaluate Xtresse Serum in Individuals With Thinning Hair NCT07228156 | Restore Biologics Holdings, Inc. dba Xtressé | N/A |
| Active Not Recruiting | Scalp Care Efficacy Evaluation for Premium Revitalizing Elixir NCT07271212 | Hungkuang University | N/A |
| Recruiting | Autologous Hair Follicle Secretome for Androgenic Alopecia (Single Site) NCT07107841 | Acorn Biolabs Inc. | N/A |
| Active Not Recruiting | Efficacy and Safety of TargetCool + Benev Exosomes in Patients With Hair Thinning NCT06999408 | Recens Medical, Inc. | N/A |
| Recruiting | 6-Month Trial of Chinese Herbal Treatments for Hair Loss and Gray Hair NCT06998680 | Vita Green Pharmaceutical (H.K.) Ltd. | N/A |
| Not Yet Recruiting | Effect of Minoxidil Solution Iontophoresis on Androgenic Alopecia NCT07056933 | Cairo University | N/A |
| Withdrawn | Evaluating Vibrational Anesthesia in Scalp Platelet Rich Plasma (PRP) NCT06497764 | NYU Langone Health | N/A |
| Completed | Evaluation of the Efficacy and Safety of Oral Roflumilast Versus Intralesional Corticosteroids Injection (ILCs NCT07174011 | Cairo University | Phase 4 |
| Enrolling By Invitation | Effectiveness of Ultrapulse for the Treatment of Androgenic Alopecia Among Malaysian: A Quasi-experimental Stu NCT06292533 | Universiti Tunku Abdul Rahman | N/A |
| Recruiting | Study to Assess the Ability of the Portable Scalp Cooling System (PSCS) to Prevent Hair Loss NCT05484973 | Cooler Heads Care Inc. | N/A |
| Completed | Using Artificial Intelligence to Help Doctors Identify Different Skin Conditions and Improve Patient Care NCT07428954 | AI Labs Group S.L | — |
| Recruiting | Portable Scalp Cooling System (PSCS) to Prevent Hair Loss for Breast Cancer Patients (Cooler Heads) NCT06215469 | University of California, San Francisco | N/A |
| Unknown | Efficacy/ Safety of DNN.22.17.036 in Male Patients With Pattern Hair Loss NCT06355856 | Ache Laboratorios Farmaceuticos S.A. | Phase 4 |
| Recruiting | Systemic Treatments for Alopecia Areata Registry NCT06283316 | Erasmus Medical Center | — |
| Recruiting | Effect of Cryotherapy in the Prevention of Madarosis Produced by Chemotherapy in Breast Cancer Patients NCT06955702 | University of Salamanca | N/A |
| Completed | In Vitro Effect Study of Interleukin-2 Muteins on Regulatory T Cells of Patients With Different Autoimmune, Al NCT05544448 | Assistance Publique - Hôpitaux de Paris | N/A |
| Completed | To Evaluate the Efficacy and Safety of GT20029 Solution in the Treatment of Androgenetic Alopecia (AGA) in Chi NCT06692465 | Suzhou Kintor Pharmaceutical Inc, | Phase 2 |
| Terminated | Study of the Characteristics of Pruritus in Patients With Frontal Fibrosing Alopecia or Lichen Planus Pilaris NCT05761158 | University Hospital, Brest | — |
| Active Not Recruiting | A Study of Oral Minoxidil to Treat Hair Loss in Children, Teens, and Young Adults Who Are Cancer Survivors NCT05778825 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Completed | Treatment of Androgenetic Alopecia in Men for 24 Weeks NCT04721548 | Eurofarma Laboratorios S.A. | Phase 3 |
| Recruiting | A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata NCT05723198 | Eli Lilly and Company | Phase 3 |
| Unknown | Mindful Parenting - A Single Case Experimental Design Study NCT05779527 | Cardiff University | N/A |
| Completed | Study of EQ101 in Adult Subjects With Moderate to Severe Alopecia Areata NCT05589610 | Equillium | Phase 2 |
| Completed | Study to Investigate the Effectiveness of a Topical Cosmetic Formulation DA-OTC-002 NCT06095739 | Applied Biology, Inc. | N/A |
| Completed | The Parallel Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of CKD-843 A NCT05587699 | Chong Kun Dang Pharmaceutical | Phase 1 |
| Recruiting | Scalp Cooling for Chemotherapy-Induced Alopecia in Patients of Color NCT05213936 | Montefiore Medical Center | N/A |
| Withdrawn | A Pilot Study to Evaluate the Use of the AMMA Portable Scalp Cooling System From Cooler Heads NCT05365243 | Cooler Heads Care Inc. | N/A |
| Unknown | Exosome Effect on Prevention of Hairloss NCT05658094 | Isfahan University of Medical Sciences | N/A |
| Unknown | Treatment of Alopecia Using Follicular Stem Cells NCT05210452 | Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus | Phase 1 / Phase 2 |
| Completed | To Evaluate Efficacy, Safety, and Tolerability of KX-826 in Male Subjects With Androgenetic Alopecia NCT05218642 | Suzhou Kintor Pharmaceutical Inc, | Phase 2 |
| Completed | To Evaluate Safety and Efficacy of KX-826 in Chinese Female Subjects With Androgenetic Alopecia NCT06409650 | Suzhou Koshine Biomedica, Inc. | Phase 2 |
| Completed | To Evaluate the Safety, Tolerability and PK of GT20029 Gel and Solution in Healthy Subjects NCT06468579 | Suzhou Kintor Pharmaceutical Inc, | Phase 1 |
| Recruiting | Study Of Cold Cap Therapy For Prevention of Hairloss in Pediatric Patients Receiving Chemotherapy For Non-Mali NCT04764357 | St. Jude Children's Research Hospital | N/A |
| Completed | A Clinical Traial to Assess Pharmacokinetic/Pharmacodynamic Profiles and Safety of CKD-843 NCT04805606 | Chong Kun Dang Pharmaceutical | Phase 1 |
| Unknown | COVID-19 Induced Telogen Effluvium NCT04834102 | Istanbul Medeniyet University | — |
| Unknown | Fractional Non-ablative Laser for the Treatment of Hair Loss NCT04953416 | Lumenis Be Ltd. | N/A |
| Completed | A Study of PRP Treatment for Hair Loss After Cancer Therapy in Women With Breast Cancer NCT04459650 | Memorial Sloan Kettering Cancer Center | EARLY_Phase 1 |
| Unknown | PBMT for the Management of CIA ( HAIRLASER ) NCT04036994 | Hasselt University | N/A |
| Completed | Keratinocyte Growth Factor- Hair Serum for the Prevention of Chemotherapy Induced Alopecia NCT04554732 | University of Arizona | EARLY_Phase 1 |
| Completed | Hair Loss Prevention Study for Pancreatic Cancer NCT04492800 | HonorHealth Research Institute | N/A |
| Recruiting | Safety and Efficacy of Fecal Microbiota Transplantation NCT04014413 | Chinese University of Hong Kong | N/A |
| Completed | LLLT for Alopecia of the Eyebrow in Women NCT04897555 | Freedom Laser Therapy, Inc. | N/A |
| Withdrawn | Fraxel Laser for Alopecia NCT03284021 | Northwestern University | N/A |
| Completed | Quality of Life Comparison in Patients With Different Types of Alopecia NCT04246957 | Centre Hospitalier Universitaire, Amiens | — |
| Completed | A Scalp Lotion Toimprove Sensitive Scalp Syndrome NCT05630027 | Cosmetique Active International | — |
| Completed | A Randomised Control Trial of Integrative Cognitive Behavioural Therapy for Alopecia NCT04205214 | City, University of London | N/A |
| Completed | The Effect of Platelet Rich Plasma on Non-scarring Alopecia NCT03689452 | Icahn School of Medicine at Mount Sinai | N/A |
| Unknown | Safety and Tolerability of Hair Stimulating Complex (HSC) in Female Pattern Hair Loss NCT03662854 | Histogen | Phase 1 |
| Completed | ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia NCT03594227 | Aclaris Therapeutics, Inc. | Phase 2 |
| Completed | ENERGI-F701 for Female Hair Loss Treatment NCT03351322 | Energenesis Biomedical Co., Ltd. | Phase 2 |
| Completed | Hair-Safe Study: Scalp Cooling for Hair Saving in Women Undergoing Chemotherapy NCT04117815 | Medical University Innsbruck | — |
| Terminated | Fractional Photothermolysis for Hair Follicle Induction NCT03382184 | University of California, Irvine | N/A |
| Unknown | Autologous Adipose-Derived Adult Stromal Vascular Cell Transplantation for Alopecia NCT03427905 | Lebanese University | N/A |
| Completed | Platelet Rich Plasma Versus Minoxidil Foam for Treatment of Androgenic Alopecia in Women NCT03488108 | Mayo Clinic | Phase 1 / Phase 2 |
| Completed | A Clinical Comparison of FDA-Cleared Photobiomodulation Devices for the Treatment of Alopecia NCT06748287 | University of Minnesota | EARLY_Phase 1 |
| Completed | Efficacy, Safety and Tolerability of CG428 Cutaneous Solution on Chemotherapy Induced Alopecia; Controlled Stu NCT02919735 | Legacy Healthcare SA | Phase 2 |
| Completed | A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males NCT02781311 | Allergan | Phase 2 |
| Completed | EValuation of the Impact of a TOpical Lotion on Permanent Chemotherapy Induced Hair Disorders in Cancer Surviv NCT02605629 | Samsung Medical Center | N/A |
| Terminated | Safety, Tolerability, and Pharmacokinetics of Bimatoprost in Men With Androgenetic Alopecia (AGA) NCT02676310 | Allergan | Phase 1 |
| Completed | A 6-month Post-interventional Follow-up Extension of VOLUME Study (VOLUME-2) NCT02986412 | Samsung Medical Center | N/A |
| Completed | Investigation of FOL-005 on Clinical Safety and Effect on Hair Growth NCT02793557 | Follicum AB | Phase 1 / Phase 2 |
| Withdrawn | Bimatoprost Ophthalmic Solution in Increasing Eyebrow and Eyelash Growth in Patients Who Have Undergone Chemot NCT00999557 | Jonsson Comprehensive Cancer Center | N/A |
| Unknown | Hair Fall in Patients on Low Dose Methotrexate NCT02591823 | Columbia Asia | — |
| Unknown | PatientSpot Formerly Known as ArthritisPower NCT03840928 | Global Healthy Living Foundation | — |
| Completed | "iRestore" Light Therapy Apparatus NCT03331003 | National Taiwan University Hospital | N/A |
| Completed | Sexual Function in Men Receiving Dutasteride for Androgenetic Alopecia NCT02014584 | Stiefel, a GSK Company | Phase 3 |
| Completed | Minoxidil Response Testing in Females With Female Pattern Hair Loss NCT02206802 | Applied Biology, Inc. | — |
| Unknown | Scalp Cooling to Prevent Chemo-induced Hair Loss NCT01986140 | Julie Nangia | N/A |
| Unknown | Hairstetics Hair Implant Device Safety and Efficacy NCT02856308 | Hairstetics | N/A |
| Unknown | Study to Assess Efficacy of Platelet-Rich Plasma in Androgenetic Alopecia NCT02393040 | Universitat Internacional de Catalunya | N/A |
| Completed | Bioequivalence Study of Dutasteride Five 0.1 mg and One 0.5 mg Soft Gelatin Capsules in Healthy Male Volunteer NCT01929330 | GlaxoSmithKline | Phase 1 |
| Completed | A Safety and Efficacy Study of Bimatoprost in Men With Androgenic Alopecia (AGA) NCT01904721 | Allergan | Phase 2 |
| Completed | A Long-term Study to Determine Safety and Efficacy of Dutasteride in Male Subjects With Androgenetic Alopecia NCT01831791 | GlaxoSmithKline | Phase 3 |
| Terminated | Compression Headband Use to Prevent Hair Loss During Whole Brain Radiotherapy NCT02935569 | Michael Milano, MD,PhD | N/A |
| Completed | Enhancing Hair Density With Platelet Rich Fibrin Matrix (PRFM) NCT01590238 | The New York Eye & Ear Infirmary | Phase 3 |
| Unknown | Hair Regrowth After Bicoronal Incision NCT01557491 | Sunnybrook Health Sciences Centre | N/A |
| Terminated | Exploratory Study of Norepinephrine to Prevent Alopecia in Head and Neck Cancer Patients Treated With Radiothe NCT01367990 | ProCertus BioPharm, Inc | Phase 1 |
| Completed | Safety and Efficacy Study of Bimatoprost in the Treatment of Men With Androgenic Alopecia NCT01325337 | Allergan | Phase 2 |
| Completed | Safety and Efficacy Study of Bimatoprost in the Treatment of Women With Female Pattern Hair Loss NCT01325350 | Allergan | Phase 2 |
| Completed | Efficacy of Platelet-Rich Plasma Versus Mesotherapy in Androgenetic Alopecia: A Retrospective Study NCT05129800 | Faculty Hospital Kralovske Vinohrady | — |
| Completed | Safety and Pharmacokinetics Study of New Formulation of Bimatoprost in Patients With Alopecia NCT01189279 | Allergan | Phase 1 |
| Unknown | Hair Counts From Vertical and Horizontal Sections of Scalp Biopsy SPecimens in Thai Population With Alopecia NCT01651689 | Siriraj Hospital | — |
| Completed | Clinical Trial in Females With Female Pattern Hair Loss NCT01145625 | Johnson & Johnson Healthcare Products Division of McNEIL-PPC, Inc. | Phase 3 |
| Completed | AVODART® Alopecia Post-marketing Surveillance (PMS) NCT01004809 | GlaxoSmithKline | — |
| Terminated | Efficacy of Hair Transplantation Compared With Hypodermic Needle Irritation in Alopecia Areata NCT01385839 | Icahn School of Medicine at Mount Sinai | N/A |
| Unknown | Safety and Efficacy of Clobetasol Propionate 0.05% E Foam in Alopecia NCT01111981 | Callender Center for Clinical Research | Phase 4 |
| Completed | START: Swiss Taxotere Alopecia Prevention Trial NCT01008774 | Sanofi | N/A |
| Unknown | Efficacy Study of Tempol to Prevent Hair Loss From Radiotherapy to the Brain NCT00801086 | Mitos Pharmaceuticals | Phase 2 |
| Completed | Prevention of Persistent Alopecia Following Docetaxel by Means of Scalp Cooling NCT00515762 | Hospital San Carlos, Madrid | Phase 2 |
| Terminated | Safety and Preliminary Efficacy Study of MTS-01 for the Prevention of Alopecia Induced by WHole Brain Radiothe NCT00713154 | Mitos Pharmaceuticals | Phase 2 |
| Completed | A Study To Assess The Efficacy And Safety Of Dutasteride 0.5mg Once Daily For 6 Months In The Treatment Of Mal NCT00441116 | GlaxoSmithKline | Phase 3 |
| Unknown | The Effect of 0.5% Roxithromycin Lotion for Androgenetic Alopecia NCT00197379 | Hamamatsu University | N/A |
| Completed | Effects of Ligands on Human Hair Follicles Grafted Onto SCID Mice NCT00177099 | Hordinsky, Maria K., MD | Phase 1 |
| Completed | Yoga-Based Rehabilitation Program in Reducing Physical and Emotional Side Effects in Patients With Cancer NCT00179348 | Albert Einstein College of Medicine | N/A |
| Terminated | Ultraviolet (UVA and UVB) Light Therapy in the Treatment of Inflammatory Skin Conditions NCT00129415 | University of Michigan | Phase 1 / Phase 2 |
| Unknown | Topical AS101 for Treatment of FAGA (Female Androgenetic Alopecia) in Menopause Women NCT00418249 | Rabin Medical Center | Phase 2 |